Patrick Baeuerle

2021

In 2021, Patrick Baeuerle earned a total compensation of $4.7M as Acting Chief Scientific Officer at Cullinan Therapeutics, a 13% decrease compared to previous year.

Compensation breakdown

Bonus$218,000
Option Awards$3,973,177
Salary$450,000
Other$34,800
Total$4,675,977

Baeuerle received $4M in option awards, accounting for 85% of the total pay in 2021.

Baeuerle also received $218K in bonus, $450K in salary and $34.8K in other compensation.

Rankings

In 2021, Patrick Baeuerle's compensation ranked 2,828th out of 12,415 executives tracked by ExecPay. In other words, Baeuerle earned more than 77.2% of executives.

ClassificationRankingPercentile
All
2,828
out of 12,415
77th
Division
Manufacturing
1,124
out of 5,508
80th
Major group
Chemicals And Allied Products
446
out of 2,378
81st
Industry group
Drugs
390
out of 2,099
81st
Industry
Biological Products, Except Diagnostic Substances
114
out of 449
75th
Source: SEC filing on April 29, 2022.

Baeuerle's colleagues

We found three more compensation records of executives who worked with Patrick Baeuerle at Cullinan Therapeutics in 2021.

2021

Nadim Ahmed

Cullinan Therapeutics

Chief Executive Officer

2021

Owen Hughes

Cullinan Therapeutics

Chief Executive Officer

2021

Jeffrey Trigilio

Cullinan Therapeutics

Chief Financial Officer

News

In-depth

You may also like